Yvan Jamilloux

7.1k total citations · 3 hit papers
142 papers, 3.6k citations indexed

About

Yvan Jamilloux is a scholar working on Physiology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yvan Jamilloux has authored 142 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Physiology, 43 papers in Ophthalmology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yvan Jamilloux's work include Sarcoidosis and Beryllium Toxicity Research (46 papers), Ocular Diseases and Behçet’s Syndrome (43 papers) and Autoimmune and Inflammatory Disorders Research (27 papers). Yvan Jamilloux is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (46 papers), Ocular Diseases and Behçet’s Syndrome (43 papers) and Autoimmune and Inflammatory Disorders Research (27 papers). Yvan Jamilloux collaborates with scholars based in France, United States and Switzerland. Yvan Jamilloux's co-authors include P. Sève, Mathieu Gerfaud‐Valentin, Thomas El Jammal, Thomas Henry, Jean Iwaz, Alexandre Bélot, C. Broussolle, Sébastien Kerever, Laurent Kodjikian and Thierry Walzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Yvan Jamilloux

125 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

2020 474 citations Yvan Jamilloux, Thomas Henry et al. profile →
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

2021 184 citations P. Sève, F. Durupt et al. profile →
Therapeutic options in VEXAS syndrome: insights from a retrospective series

2021 161 citations Thomas Barba, Jean‐Christophe Lega et al. profile →

Peers

Countries citing papers authored by Yvan Jamilloux

Since Specialization

Citations

This map shows the geographic impact of Yvan Jamilloux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvan Jamilloux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvan Jamilloux more than expected).

Fields of papers citing papers by Yvan Jamilloux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvan Jamilloux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvan Jamilloux. The network helps show where Yvan Jamilloux may publish in the future.

Co-authorship network of co-authors of Yvan Jamilloux

This figure shows the co-authorship network connecting the top 25 collaborators of Yvan Jamilloux. A scholar is included among the top collaborators of Yvan Jamilloux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvan Jamilloux. Yvan Jamilloux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	La médecine interne : une discipline centrale des établissements de santé pour le soin aux malades complexes 2025 ·La Revue de Médecine Interne ·Quitterie Reynaud, (unknown), (unknown), P. Sève, A. Hot, M. Richard, (unknown), Yvan Jamilloux, Thomas Barba, (unknown), I. Durieu	0
2	Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis 2025 ·Ophthalmology ·(unknown), P. Sève, (unknown), (unknown), Georgina Maalouf, Laurent Kodjikian, (unknown), Yvan Jamilloux, (unknown), (unknown), F. Domont, (unknown), Amine Ghembaza, P. Cacoub, (unknown), (unknown), (unknown), Bahram Bodaghi, David Saadoun, A.C. Desbois	0
3	Therapeutic impact of basic critical care echocardiography performed by residents after limited training 2024 ·Annals of Intensive Care ·Marine Goudelin, Bruno Evrard, (unknown), (unknown), (unknown), (unknown), (unknown), François-Xavier Lapébie, Yvan Jamilloux, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Philippe Vignon	0
4	Neural networks for predicting etiological diagnosis of uveitis 2024 ·Eye ·(unknown), (unknown), Tao Wang, (unknown), Antoine Duclos, Laurent Kodjikian, Yvan Jamilloux, (unknown), P. Sève	1
5	Minor Salivary Gland Biopsy for the Diagnosis of Neurosarcoidosis 2023 ·European Neurology ·Nicolas Fournier, Yvan Jamilloux, Mathieu Gerfaud‐Valentin, Nathalie Streichenberger, Sandra Vukusic, Romain Marignier, G. Androdias, P. Sève	0
6	H syndrome treated with Tocilizumab: two case reports and literature review 2023 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), M. Richard, Yvan Jamilloux, (unknown), Jean‐François Emile, Julien Haroche, Lars Steinmüller, (unknown), Alice Phan, Alexandre Bélot, P. Sève	3
7	Infection de l’adulte à Parvovirus 2022 ·La Revue de Médecine Interne ·(unknown), Mathieu Gerfaud‐Valentin, Yahia Mekki, Geneviève Billaud, Yvan Jamilloux, P. Sève	8
8	Diagnosing Hemophagocytic Lymphohistiocytosis with Machine Learning: A Proof of Concept 2022 ·Journal of Clinical Medicine ·Thomas El Jammal, (unknown), (unknown), Maxime Fauter, P. Sève, Yvan Jamilloux	2
9	The Spectrum of Still’s Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 Patients 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Nicolas Fournier, (unknown), (unknown), K.H. Ly, Mathieu Gerfaud‐Valentin, Laurent Pérard, (unknown), (unknown), (unknown), A. Hot, Alexandre Bélot, I. Durieu, P. Sève, Yvan Jamilloux	5
10	Murine typhus complicated by sHLH mimicking adult-onset Still's disease 2022 ·La Revue de Médecine Interne ·(unknown), Mathieu Gerfaud‐Valentin, Jean‐Christophe Lega, Ann De Becker, Yvan Jamilloux, P. Sève	3
11	Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment 2021 ·British Journal of Ophthalmology ·(unknown), Pierre Pradat, Yvan Jamilloux, Mathieu Gerfaud‐Valentin, (unknown), S. Trad, P. Sève	4
12	Saddle Nose Deformity in Sarcoidosis 2021 ·The American Journal of Medicine ·(unknown), Arthur A. Bert, F. Durupt, Yvan Jamilloux, P. Sève	0
13	Refractory Sarcoidosis: A Review 2020 ·SHILAP Revista de lepidopterología ·(unknown), Yvan Jamilloux, Mathieu Gerfaud‐Valentin, Dominique Valeyre, P. Sève	1
14	Low glycosylated ferritin is a sensitive biomarker of severe COVID-19 2020 ·Cellular and Molecular Immunology ·Maxime Fauter, Sébastien Viel, (unknown), Pierre Pradat, (unknown), Marine Villard, Lorna Garnier, Thierry Walzer, P. Sève, Thomas Henry, Yvan Jamilloux	8
15	Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis 2020 ·British Journal of Ophthalmology ·(unknown), Pierre Pradat, (unknown), Yvan Jamilloux, P. Sève	10
16	Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis) 2020 ·British Journal of Ophthalmology ·(unknown), Yvan Jamilloux, (unknown), Marie‐Hélène Errera, Laurent Pérard, G. Pugnet, N. Tieulié, Marc André, P. Bielefeld, Alain M. Bron, Évelyne Decullier, Sylvie Bin, P. Sève	6
17	A proximity-dependent biotinylation (BioID) approach flags the p62/sequestosome-1 protein as a caspase-1 substrate 2018 ·Journal of Biological Chemistry ·Yvan Jamilloux, Brice Lagrange, (unknown), Emilie Bourdonnay, (unknown), (unknown), Thomas Henry, Fabio Martinon	19
18	AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity 2016 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Jérôme Lugrin, Yvan Jamilloux, (unknown), Aubry Tardivel, Aude De Gassart, Léa Zaffalon, (unknown), Stefanie Siegert, Manfredo Quadroni, Petr Brož, Thomas Henry, Christine A. Hrycyna, Fabio Martinon	115
19	Hemophagocytic Lymphohistiocytosis in Intensive Care Unit 2015 ·Medicine ·Thomas Barba, Delphine Maucort‐Boulch, Jean Iwaz, Julien Bohé, J. Ninet, A. Hot, Jean‐Christophe Lega, Claude Guérin, Laurent Argaud, (unknown), Yvan Jamilloux, Jean‐Christophe Richard, P. Sève	43
20	Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases 2015 ·British Journal of Ophthalmology ·(unknown), Laurent Kodjikian, Delphine Maucort‐Boulch, Laurent Pérard, Jean Iwaz, Yvan Jamilloux, C. Broussolle, C. Burillon, P. Sève	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact